Evidence map›Paper›PMID 37056072›Full record

ReviewThe Indian journal of medical research2022

Simplified clinical algorithm for immediate antiretroviral therapy initiation: The HATI [HIV awal (early) Test & Treat in Indonesia] implementation research in Indonesia.

Yanri Wijayanti Subronto, Nur Aini Kusmayanti, Pande Putu Januraga, Late Nyoman Dewa Wirawan, Rudi Wisaksana, Evi Sukmaningrum, Nurhayati Hamim Kawi, Shelly Iskandar, Tri Mulyani, Nurjannah Sulaiman and 3 more

Open access · diamondAbstract readReview
In one paragraph

Review in The Indian journal of medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Yanri Wijayanti SubrontoCenter for Tropical Medicine; Department of Internal Medicine, Division of Tropical Medicine & Infectious Diseases, Faculty of Medicine, Public Health, & Nursing, Gadjah Mada University, Yogyakarta, Indonesia.
Nur Aini KusmayantiCenter for Tropical Medicine, Gadjah Mada University, Yogyakarta, Indonesia.
Pande Putu JanuragaCenter for Public Health Innovation, Faculty of Medicine, Udayana University, Bandung, Indonesia.
Late Nyoman Dewa WirawanYayasan Kerti Praja, Denpasar, Bali, Indonesia.
Rudi WisaksanaResearch Center for Care and Control of Infectious Disease, Faculty of Medicine, Padjajaran University, Bandung, Indonesia.
Evi SukmaningrumDepartment of Psychology; Centre of Excellence Health Policy and HIV-AIDS, Jakarta, Indonesia.
Nurhayati Hamim KawiDepartment of Public Health, University of Indonesia, Depok (Kota), Indonesia.
Shelly IskandarResearch Center for Care and Control of Infectious Disease, Faculty of Medicine, Padjajaran University, Bandung, Indonesia.
Tri MulyaniResearch Center for Care and Control of Infectious Disease, Faculty of Medicine, Padjajaran University, Bandung, Indonesia.
Nurjannah SulaimanIndonesia Ministry of Health, Directorate Communicable Disease Control, Sydney, New South Wales, Australia.
Robert MagnaniHIV-AIDS Research Centre, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
John KaldorKirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Matthew LawKirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Padjadjaran University · IDUniversitas Gadjah Mada · IDUNSW Sydney · AUAIDS United · USAtma Jaya Catholic University of Indonesia · IDMinistry of Health · IDUdayana University · IDUniversity of Indonesia · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & objectives: Although the World Health Organization recommends same day or rapid (< seven days) antiretroviral therapy (ART) initiation, delays in ART initiation remain common due to waiting for laboratory test results. This study employed a simplified clinical algorithm the HATI [HIV Awal (Early) Test & Treat Indonesia]-SAI (Simple ART Initiation) aimed to increase the proportion of ART uptake and decrease the time to ART initiation that can be used in various care settings. Methods: This study compared the percentage of ART uptake and retention, viral load (VL) suppression and time to ART initiation between the observation and intervention phases among newly diagnosed HIV patients from key populations. As part of the intervention, the newly diagnosed patients underwent screening using a simple form [consisting of data on age, height and weight (for body mass index calculation), questions on the presence of symptoms of HIV stages 1 and 2, tuberculosis, history of diabetes, hypertension and kidney disease], to determine eligibility for immediate ART initiation. Those who met the pre-defined criteria immediately received a combination of tenofovir lamivudine and efavirenz for two weeks. The baseline laboratory examination due to this was moved up to two weeks post ART. Factors significantly associated with ART uptake were also determined and their odds ratios were measured using logistic regression analysis. Results: A total of 2173 people newly diagnosed with HIV were recruited, with 1579 and 594 in the observation and intervention phases, respectively. In both phases, the majority were men who have sex with men, who were young (<30 yr old) and employed, with high levels of education. The intervention phase significantly increased the proportion of ART initiation [91%, 95% confidence interval (CI): 89-93% vs. 78%, 95% CI: 76-80%] but did not have any impact on the proportion of six months retention and VL suppression. The intervention also significantly decreased the time to ART initiation from median ± interquartile range: 9±20 days to 2±10 days. Interpretation & conclusions: The findings of this study suggest that the HATI-SAI intervention increased the uptake and decreased the time for immediate ART initiation. The HATI-SAI provides a simple and safe clinical approach that can readily be adopted in different settings without a costly investment in technology.

Indexed as

Anti-HIV AgentsHIV InfectionsSexual and Gender MinoritiesAlgorithmsFemaleHomosexuality, MaleHumansIndonesiaMaleViral LoadAnti-HIV AgentsARTEarly HIV Awal Test and Treat IndonesiaHATI SAIHIV-AIDS

Identifiers

PMID37056072
PMCPMC10278919
OpenAlexW4363609653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.